Abstract
Purpose. To develop a clinical alternative to drug administration by injection or infusion.
Methods. A simple, mechanical device (Cellpatch) enables both the formation of a standardized small epidermal bleb and exposure of the circular base of the bleb to drug. The epidermis is split off by suctioning without bleeding or discomfort in a layer superficial to dermal capillaries and nociceptor nerves. Transdermal invasivity is thus avoided. Absorption of dextran test drug in aqueous solution vs molecular weight (3 kDa–70 kDa) and erosion area (3 kDa, diameter: 3–10 mm) were studied in healthy volunteers. The feasibility of using Morphine cell-patch (cell filled with 20 mg/ml morphine hydrochloride, aqueous solution, erosion diameter 6 mm) for post-operative pain relief was studied in two different patient groups; the Cellpatch was removed after 48 hours. Plasma morphine concentrations were determined at intervals.
Results. Dextrans of all sizes were efficiently absorbed transdermally, although absorption decreased with increasing molecular weight. The degree of absorption was directly related to the area of the mini-erosion. There were no sign of dose-dumping even with the largest erosions. The Cellpatch performed well in the demanding conditions of the postoperative unit, and was considered easy to use. Pharmacokinetically, the postoperative morphine delivery was related to that of a continuous infusion, with variability and dose in the same range as a continuous morphine infusion used clinically for providing basal pain relief. There were no bacterial growth in the morphine cells at 48 h. Reepithelialization of the erosion was rapid.
Conclusions. The feasibility of administering drugs in a wide size range by passive diffusion through a standardized skin mini-erosion was demonstrated; the rate of absorption decreased with increasing molecular weight. The small area of the erosion restricts and controls the concentration driven diffusion of drug into the circulation. As a consequence of the favorable findings, three placebo-controlled clinical studies using Morphine cellpatch for postoperative pain relief are currently underway.
Similar content being viewed by others
REFERENCES
R. Langer. New methods of drug delivery. Science 249:1527–1533 (1990).
R. Langer. Polymer-controlled drug delivery systems. Acc. Chem. Res. 26:537–642 (1993).
P. Svedman, S. Lundin and Ch. Svedman. Administration of antidiuretic peptide (DDAVP) by way of suction deepithelialised skin. Lancet 337:1506–9 (1991).
D. Westerling, P. Höglund, S. Lundin and P. Svedman. Transdermal administration of morphine to healthy subjects. Br. J. clin. Pharmacol. 37:571–6 (1994).
S. Lundin, P. Svedman, P. Höglund, K. Jönsson, A. Broeders and P. Melin. Absorption of an oxytocin analogue (antocin) and a vasopressin analogue (dDAVP) through a standardized skin erosion in volunteers. Pharm. Res. 12:2024–2029 (1995).
U. Kiistala. The suction blister method for the in vivo separation of epidermis from dermis in human skin. Thesis, University of Helsinki, Finland 1976.
W.S. Krawczyk. A pattern of epidermal cell migration during wound healing. J. Cell. Biol. 49:247–63 (1971).
P. Svedman, C. Svedman and I. Njalsson. Epithelialization and blood flow in suction blister wounds in healthy volunteers. J. Invest. Surg. 4:175–89 (1991).
N. Kutlu and P. Svedman. Structural microvessel response in dermis of suction blister wounds on upper and lower limbs in healthy volunteers. Vasc. Surg. 26:290–9 (1992).
N. Kutlu and P. Svedman. Suction blister wounding, morphological and functional aspects. Vasc. Surg. 26:388–99 (1992).
N. Kutlu and P. Svedman. The microcirculation in suction blister wounds on upper and lower limb in healthy volunteers. Vasc. Surg. 26:706–11 (1992).
G. Grotte. Passage of dextran molecules across the blood-lymph barrier. Acta Chir. Scand. Suppl. 211:1–84 (1956).
A. Bollinger, G. Pfister, U. Hoffmann and U. K. Franzeck. Fluorescence microlymphography in chronic venous incompetence. Inter. Angio. Suppl. 8:23–6 (1989).
J. O. Svensson. Determination of morphine, morphine-6-glucuronide and nor-morphine in plasma and urine with high-performance liquid chromatography and electrochemical detection. J. Chromatogr. 375:174–8 (1986).
E. Svensjö, K. E. Arfors, R. M. Raymond and G. J. Grega. Morphological and physiological correlation of bradykinin-induced macromolecular flux. Am. J. Physiol. 236:H600–6 (1979).
B. J. Vermeer, F. C. Reman and C. M. van Gent. The determination of lipids and proteins in suction blister fluid. J. Invest. Dermatol. 73:303–5 (1979).
K.A. Lehmann and D. Zech. Transdermal fentanyl: clinical pharmacology. J. Pain Symptom. Manage. 7:8–16 (1992).
D. Westerling. Studies on morphine and its main metabolites in man and rat, with special reference to some non-analgesic effects and pharmacokinetics after different routes of administration. Thesis, University of Lund, Sweden, 1993.
P. Fiset, C. Cohane, S. Browne, S. C. Brand and S. L. Shafer. Biopharmaceutics of a new transdermal fentanyl device. Anesthesiology. 83:459–469 (1995).
P. Autio. Markers of collagen metabolism in suction blister fluid and serum. Thesis, University of Oulu, Finland, 1994.
K. B. Hellum and V. Lehmann. Penetration of benzylpenicillin to human tissue fluid in subcutaneous wicks and skin blisters. Acta. Med. Scand. Suppl. 621:35 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svedman, P., Lundin, S., Höglund, P. et al. Passive Drug Diffusion via Standardized Skin Mini-erosion; Methodological Aspects and Clinical Findings with New Device. Pharm Res 13, 1354–1359 (1996). https://doi.org/10.1023/A:1016021900286
Issue Date:
DOI: https://doi.org/10.1023/A:1016021900286